Evidence map›Paper›PMID 35690929›Full record

SynthesisThe Journal of clinical endocrinology and metabolism2022

A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.

Mohamed O Seisa, Samer Saadi, Tarek Nayfeh, Kalpana Muthusamy, Sahrish H Shah, Mohammed Firwana, Bashar Hasan, Tabinda Jawaid, Rami Abd-Rabu, Mary T Korytkowski and 9 more

Registry-linked trialOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05803473 (In-hospital Diabetes Management by a Diabetes Team and Continuous Glucose Monitoring or Point of Care Glucose Testing), which is not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05803473 nacompletednot on this mapstarted 2023, after this paper: background citation

In-hospital Diabetes Management by a Diabetes Team and Continuous Glucose Monitoring or Point of Care Glucose Testing (DIATEC): a Randomised Trial

TypeinterventionalSponsorPeter KristensenRan2023 to 2024Enrolled166ConditionsDiabetes Mellitus, Type 2ArmsDexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA), FreeStyle Precision Pro Glucometer for glucose POC testing
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Random Blood Glucose: Episode 1.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Mohamed O SeisaMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.ORCID 0000-0002-5179-4264
Samer SaadiMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Tarek NayfehMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Kalpana MuthusamyOlmsted Medical Center, Rochester, MN, USA.
Sahrish H ShahMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Mohammed FirwanaMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Bashar HasanMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Tabinda JawaidMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Rami Abd-RabuMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Mary T KorytkowskiUniversity of Pittsburgh,Pittsburgh, PA, 15260, USA.
Ranganath MuniyappaNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.ORCID 0000-0003-4198-1055
Kellie Antinori-LentUPMC Shadyside, Pittsburgh, PA 15232, USA.
Amy C DonihiUniversity of Pittsburgh School of Pharmacy,Pittsburgh, PA 15261, USA.
Andjela T DrincicUniversity of Nebraska Medical Center,Omaha, NE 68198, USA.
Anton LugerMedical University and General Hospital of Vienna, Austria.
Victor D Torres RoldanMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Meritxell UrtechoMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Zhen WangMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
M Hassan MuradMayo Clinic Evidence-Based Practice Center, Rochester, MN, USA.
Mayo Clinic · USUniversity of Pittsburgh · USNational Institutes of Health · USOlmsted Medical Center · USShadyside Hospital · USUniversity of Nebraska Medical Center · USVienna General Hospital · AT

Funding

The NIH Inter-Institute Training Program in Endocrinology, Diabetes & MetabolismZIEDK075100 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI MUNIYAPPA, RANGANATH · 2009 to 2025
$18.0M
6 · The paper itself

Abstract

contextIndividuals with diabetes or newly recognized hyperglycemia account for over 30% of noncritically ill hospitalized patients. Management of hyperglycemia in these patients is challenging.

objectiveTo support development of the Endocrine Society Clinical Practice Guideline for management of hyperglycemia in adults hospitalized for noncritical illness or undergoing elective surgical procedures.

methodsWe searched several databases for studies addressing 10 questions provided by a guideline panel from the Endocrine Society. Meta-analysis was conducted when feasible. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess certainty of evidence.

resultsWe included 94 studies reporting on 135 553 patients. Compared with capillary blood glucose, continuous glucose monitoring increased the number of patients identified with hypoglycemia and decreased mean daily blood glucose (BG) (very low certainty). Data on continuation of insulin pump therapy in hospitalized adults were sparse. In hospitalized patients receiving glucocorticoids, combination neutral protamine hagedorn (NPH) and basal-bolus insulin was associated with lower mean BG compared to basal-bolus insulin alone (very low certainty). Data on NPH insulin vs basal-bolus insulin in hospitalized adults receiving enteral nutrition were inconclusive. Inpatient diabetes education was associated with lower HbA1c at 3 and 6 months after discharge (moderate certainty) and reduced hospital readmissions (very low certainty). Preoperative HbA1c level < 7% was associated with shorter length of stay, lower postoperative BG and a lower number of neurological complications and infections, but a higher number of reoperations (very low certainty). Treatment with glucagon-like peptide-1 agonists or dipeptidyl peptidase-4 inhibitors in hospitalized patients with type 2 diabetes and mild hyperglycemia was associated with lower frequency of hypoglycemic events than insulin therapy (low certainty). Caloric oral fluids before surgery in adults with diabetes undergoing surgical procedures did not affect outcomes (very low certainty). Counting carbohydrates for prandial insulin dosing did not affect outcomes (very low certainty). Compared with scheduled insulin (basal-bolus or basal insulin + correctional insulin), correctional insulin was associated with higher mean daily BG and fewer hypoglycemic events (low certainty).

conclusionThe certainty of evidence supporting many hyperglycemia management decisions is low, emphasizing importance of shared decision-making and consideration of other decisional factors.

Indexed as

Diabetes Mellitus, Type 2HyperglycemiaAdultBlood GlucoseBlood Glucose Self-MonitoringElective Surgical ProceduresGlycated HemoglobinHumansHypoglycemic AgentsInsulinBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulincarbohydrate countingdiabetesendocrine societyhyperglycemianon-insulin therapiessliding scale insulin

Identifiers

PMID35690929
PMCPMC9653020
OpenAlexW4281780193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.